Literature DB >> 26613882

Functional MR Imaging in Gynecologic Cancer.

Nandita M deSouza1, Andrea Rockall2, Susan Freeman3.   

Abstract

Dynamic-contrast enhanced (DCE) and diffusion-weighted (DW) MR imaging are invaluable in the detection, staging, and characterization of uterine and ovarian malignancies, for monitoring treatment response, and for identifying disease recurrence. When used as adjuncts to morphologic T2-weighted (T2-W) MR imaging, these techniques improve accuracy of disease detection and staging. DW-MR imaging is preferred because of its ease of implementation and lack of need for an extrinsic contrast agent. MR spectroscopy is difficult to implement in the clinical workflow and lacks both sensitivity and specificity. If used quantitatively in multicenter clinical trials, standardization of DCE- and DW-MR imaging techniques and rigorous quality assurance is mandatory.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Characterization; Detection; Diffusion-weighted; Dynamic contrast-enhanced; Gynecologic cancer; Recurrence; Response; Staging

Mesh:

Substances:

Year:  2015        PMID: 26613882     DOI: 10.1016/j.mric.2015.08.008

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  4 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  Constructing an ovarian cancer metastasis index by dissecting medical records.

Authors:  Yanjun Qu; Yanan He; Zhangming Li; Xiuwei Chen; Qian Liu; Shuangshuang Zou; Congcong Kong; Yixiu Liu; Ce Gao; Guangmei Zhang; Wenliang Zhu
Journal:  Oncotarget       Date:  2017-11-06

3.  MR guided high intensity focused ultrasound (MRgHIFU) for treating recurrent gynaecological tumours: a pilot feasibility study.

Authors:  Sharon L Giles; Georgios Imseeh; Ian Rivens; Gail R Ter Haar; Alexandra Taylor; Nandita M deSouza
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

4.  Combination Analysis of a Radiomics-Based Predictive Model With Clinical Indicators for the Preoperative Assessment of Histological Grade in Endometrial Carcinoma.

Authors:  Tao Zheng; Linsha Yang; Juan Du; Yanchao Dong; Shuo Wu; Qinglei Shi; Xiaohan Wang; Lanxiang Liu
Journal:  Front Oncol       Date:  2021-06-21       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.